Editorial: Mechanistic and therapeutic advances in antibody-mediated rejection: reasons to be optimistic
Curr Opin Organ Transplant
.
2022 Oct 1;27(5):369-370.
doi: 10.1097/MOT.0000000000001020.
Authors
Manuel Alfredo Podestà
1
,
Paolo Cravedi
2
Affiliations
1
Nephrology Unit, Department of Health Sciences, Università degli Studi di Milano, Italy.
2
Translational Transplant Research Center (TTRC), Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
PMID:
36102358
PMCID:
PMC9484036
DOI:
10.1097/MOT.0000000000001020
No abstract available
Publication types
Editorial
MeSH terms
Antibodies*
Graft Rejection* / prevention & control
Humans
Substances
Antibodies
Grants and funding
R01 AI132949/AI/NIAID NIH HHS/United States